Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry.
about
Biophysical aspects of lysozyme adduct with monocrotophosMetabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic aminesBiomonitoring Human Albumin Adducts: The Past, the Present, and the FutureHPLC separation of human serum albumin isoforms based on their isoelectric points.Enrichment of cysteinyl adducts of human serum albumin.A sandwich enzyme-linked immunosorbent assay for adducts of polycyclic aromatic hydrocarbons with human serum albumin.Conversion of S-phenylsulfonylcysteine residues to mixed disulfides at pH 4.0: utility in protein thiol blocking and in protein-S-nitrosothiol detection.Adductomics: characterizing exposures to reactive electrophilesPhysiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect.Selective trapping of SNO-BSA and GSNO by benzenesulfinic acid sodium salt: mechanistic study of thiosulphonate formation and feasibility as a protein S-nitrosothiol detection strategyOxidation of the albumin thiol to sulfenic acid and its implications in the intravascular compartment.The thiol pool in human plasma: the central contribution of albumin to redox processes.Pre-association of polynuclear platinum anticancer agents on a protein, human serum albumin. Implications for drug design.A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field.Covalent Modifications of Albumin Cys34 as a Biomarker of Mild Oxidative StressHuman serum albumin cysteinylation is increased in end stage renal disease patients and reduced by hemodialysis: mass spectrometry studies
P2860
Q27690801-EFB3548A-B7DA-4525-9F4D-FD8D2E808D75Q28391158-E68696E7-1F93-4737-B0BB-98F44733849DQ28468289-834ED424-E4E6-4A9D-A532-AF4F71A526C3Q33685183-17EA5A3A-651C-49A4-8A7C-0617AAC152DDQ33716580-CA3536B4-AE98-4B5B-8E07-9DDBFAF66330Q33741504-28A10708-ACE3-4208-A3DF-8548F986C7CAQ35195217-2ED0682D-5480-4D2E-876A-9FAD9B301A44Q36592967-DF2BBCEF-1B67-4773-AEC8-FB0DE8BC1A87Q36807461-5F5B97CA-8925-4A9A-B566-8F231C295A0DQ36970464-C21125A0-7E11-4F4F-8248-84258E6B856CQ37265068-C2F87877-CD8A-4EA2-9F02-68E0AFB684E8Q37426325-7645F971-CCD3-43EB-8877-90672D68D4F5Q37540768-9639FB30-A018-4D40-8EF3-09635A973CA7Q42012350-26665E27-0F4A-42D8-8865-9F8EF4E438FEQ45799435-3568BB35-119A-4A77-BE20-1917992C4676Q57012501-C0FB54BF-BF6E-4F8E-A266-23757F2B4CD0Q57230730-5CE44A21-BCEA-49E2-A709-A3584FD460AE
P2860
Direct observation of covalent adducts with Cys34 of human serum albumin using mass spectrometry.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Direct observation of covalent ...... bumin using mass spectrometry.
@en
Direct observation of covalent ...... bumin using mass spectrometry.
@nl
type
label
Direct observation of covalent ...... bumin using mass spectrometry.
@en
Direct observation of covalent ...... bumin using mass spectrometry.
@nl
prefLabel
Direct observation of covalent ...... bumin using mass spectrometry.
@en
Direct observation of covalent ...... bumin using mass spectrometry.
@nl
P2093
P356
P1476
Direct observation of covalent ...... bumin using mass spectrometry.
@en
P2093
John de Jersey
Margaret M Sheil
Sarah R Yong
Shanika Ambahera
Stephen F Ralph
P304
P356
10.1016/J.AB.2003.10.041
P407
P577
2004-02-01T00:00:00Z